MedTrace Logo

Evaluation of Surfactant Protein B in the Differential Diagnostics of Dyspnea

NCT01197586 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2013-06-24

No results posted yet for this study

Summary

Establishing new biochemical markers in the differential diagnostics and risk stratification in heterogeneous patient collectives is becoming more and more important. The markers should be objective, reliable, reproducible, quick and cost effective as well as specific and sensitive. Concerning the differential diagnostics of "dyspnea", NT-pro-BNP plays the most important role for the evaluation of a cardiac origin. However, a corresponding biochemical marker for pulmonary stress is lacking. The aim of the study at hand therefore was the evaluation of surfactant protein B in the differential diagnostics of pulmonary and cardiac diseases.

Conditions

  • Dyspnea
  • Cardiac Disease
  • Pulmonary Disease

Sponsors & Collaborators

  • Roche Diagnostics GmbH

    collaborator INDUSTRY

  • Universitätsmedizin Mannheim

    lead OTHER

Principal Investigators

  • Joachim Saur, MD · Universitätsmedizin Mannheim

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197586 on ClinicalTrials.gov